<DOC>
	<DOCNO>NCT00638053</DOCNO>
	<brief_summary>The purpose study assess prevalence GHD patient sustain head injury suffer major traumatic event evaluate efficacy growth hormone ( GH ) therapy treatment GHD cause trauma head injury</brief_summary>
	<brief_title>A Study Evaluate Efficacy Somatropin Adults With Growth Hormone Deficiency Caused Trauma and/or Head Injury</brief_title>
	<detailed_description>The study terminate October 9 , 2003 . The reason cite termination due poor patient recruitment therefore enough data could collect provide comprehensive analysis reporting result . No safety efficacy issue report cause termination study .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Documented GHD Documented mild , moderate , severe head injury ( e.g. , Glasgow COMA Scale score less equal 15 equivalent measure ) Active systemic malignancy active intracranial tumor Growth hormone replacement therapy last 12 month History dementia unrelated traumatic brain injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>